Franchise Capital’s ACM Research ACMR Stock Holding History

Franchise Capital’s Portfolio ACMR Stock Details ACMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-506,433	Closed	-$3.9M	–	21
2022 Q4	$3.9M	Buy	+506,433	New	+$4.29M	1.2%	13

Other funds holding ACMR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Franchise Capital's ACMR Position: Q1 2023 in Review

Franchise Capital sold out of ACM Research (ACMR) in Q1 2023, closing a stake of 506,433 shares — an estimated $3.9M sold.

Franchise Capital first reported a position in ACMR in Q4 2022 and held it in 1 quarter. The position peaked at $3.9M in Q4 2022. 129 funds tracked by Wall St. Rank hold ACMR as of Q1 2023.

Franchise Capital reported no remaining ACM Research position as of Q1 2023 after selling out during the quarter.
Franchise Capital sold 506,433 ACM Research shares in Q1 2023, an estimated $3.9M.
Franchise Capital first reported a position in ACM Research in Q4 2022 and held it in 1 quarter.
Franchise Capital's ACM Research position peaked at $3.9M in Q4 2022.
129 funds tracked by Wall St. Rank held ACM Research as of Q1 2023.

Based on Franchise Capital's 13F filing for Q1 2023, filed 15 May 2023.